Category: Disease States

Disease States

OncoHost Receives New York State Laboratory Permit for Precision Oncology Test

The permit enables the company to offer its PROphetNSCLC test to physicians and patients across New York State, completing nationwide availability.

Disease States

Circulogene Launches Tissue-Based Genomic Profiling Assay for Solid Tumors

OncoGenDx analyzes 335 DNA genes and 72 RNA genes using next-generation sequencing technology to support treatment decisions.

Disease States

FDA Clears Hologic’s Molecular GI Pathogen Tests

New assays detect common bacterial causes of infectious gastroenteritis using molecular technology on existing diagnostic platforms.

Cancer

Genetic Test Now Available to Predict Radiation Therapy Side Effects in Prostate Cancer

PROSTOX ultra identifies patients at higher risk of developing late genitourinary toxicity from stereotactic body radiation therapy.

Infectious Diseases

Industry Leaders Convene Summit on Antimicrobial Resistance Diagnostics

The two-day meeting brought together physicians, microbiologists, and policymakers to address rising threat of drug-resistant infections.

Womens Health

Fellow Health Joins Progyny Network for Home Male Fertility Testing

Partnership provides mail-in semen analysis as a covered benefit for eligible members.

Allergy & Autoimmune

Why Laboratory Insights Are Critical During Asthma Peak Week

From rising demand for comprehensive IgE profiles to the emergence of molecular allergen diagnostics, laboratories are central to how clinicians prepare for and manage September’s asthma spike.

Cardiovascular, Cerebrovascular

Sixth-Generation Troponin T Test Shows High Accuracy for Heart Attack Diagnosis

Study of more than 13,000 individuals demonstrates improved precision for emergency department triage and patient outcomes.

Dementias & Alzheimer’s

C2N Diagnostics Lowers Age Limit for Alzheimer’s Blood Test to 50

C2N Diagnostics has expanded the intended use of its PrecivityAD2 Alzheimer's disease blood test to include patients 50 years and older, lowering the previous age limit from 60 years.

Diabetes & Metabolic Diseases

Revvity Expands Type 1 Diabetes Testing Program with Sanofi Support

Initiative includes IVD assay development and lab-developed test expansion for early-stage disease screening.

Kidney Disease

Carna Health, Siemens Healthineers Partner on AI-Enabled CKD Platform

The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.

Respiratory Disease

Yourgene Health Cystic Fibrosis Assay Receives IVDR Accreditation

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Sepsis

AI-Powered Sepsis Test Shows Promise in Large Clinical Study

TriVerity system demonstrated high sensitivity and specificity across more than 1,200 patients in pivotal SEPSIS-SHIELD trial.